Clinical Trials Directory

Trials / Completed

CompletedNCT00332072

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
541 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in the treatment of glaucoma or ocular hypertension

Conditions

Interventions

TypeNameDescription
DRUGbimatoprost/timolol fixed combination

Timeline

Start date
2001-08-01
Primary completion
2003-08-01
Completion
2003-08-01
First posted
2006-06-01
Last updated
2011-05-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00332072. Inclusion in this directory is not an endorsement.